{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:57:24Z","timestamp":1758981444822},"reference-count":11,"publisher":"Societas Neurologica Japonica","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rinsho Shinkeigaku"],"published-print":{"date-parts":[[2012]]},"DOI":"10.5692\/clinicalneurol.52.567","type":"journal-article","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T22:53:19Z","timestamp":1346799199000},"page":"567-570","source":"Crossref","is-referenced-by-count":5,"title":["Reversible posterior leukoencephalopathy syndrome (RPLS) associated with Wegener's granulomatosis: A case report and review of the literature"],"prefix":"10.5692","volume":"52","author":[{"given":"Rieko","family":"Onozawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyoshi","family":"Obata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirosato","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhisa","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3663","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.","DOI":"10.1056\/NEJM199602223340803"},{"key":"2","unstructured":"2) Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion weighted MR images. AJNR Am J Neuroradiol 2002;23:1038-1048."},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-006-0086-2"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Lewis GD, Campbell WB, Johnson AR. Inhibition of prostaglandin synthesis by glucocorticoids in human endothelial cells. Endocrinology 1986;119:62-69.","DOI":"10.1210\/endo-119-1-62"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Mukherjee P, McKinstry RC. Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging. Radiology 2001;219:756-765.","DOI":"10.1148\/radiology.219.3.r01jn48756"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;60:1614-1627.","DOI":"10.7326\/0003-4819-116-6-488"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Nishio M, Yoshioka K, Yamagami K, et al. Reversible posterior leukoencephalopathy syndrome: a possible manifestation of Wegener's granulomatosis-mediated endothelial injury. Mod Rheumatol 2008;18:309-314.","DOI":"10.3109\/s10165-008-0052-1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Ohta T, Sakano T, Shiotsu M, et al. Reversible posterior leukoencephalopathy in a patient with Wegener granulomatosis. Pediatr Nephrol 2004;19:442-444.","DOI":"10.1007\/s00467-003-1286-y"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Gorman G, Hutchinson M, Tubridy N. Clinical reasoning: a case of Wegener granulomatosis complicated by seizures and headaches: curiouser and curiouser. Neurology 2009;72:e11-14.","DOI":"10.1212\/01.wnl.0000339489.16519.17"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.5.534"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Preston GA, Yang JI, Xiao H, et al. Understanding the pathogenesis of ANCA: where are we today? Cleve Clin J Med 2002;69 Suppl 2:S II 51-54.","DOI":"10.3949\/ccjm.69.Suppl_2.SII51"}],"container-title":["Rinsho Shinkeigaku"],"original-title":["Wegener\u8089\u82bd\u816b\u75c7\u6cbb\u7642\u4e2d\u306b\u767a\u75c7\u3057\u305fReversible posterior leukoencephalopathy syndrome"],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T20:04:53Z","timestamp":1621541093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/clinicalneurol\/52\/8\/52_567\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.5692\/clinicalneurol.52.567","relation":{},"ISSN":["0009-918X","1882-0654"],"issn-type":[{"value":"0009-918X","type":"print"},{"value":"1882-0654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}